PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940978
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940978
Point Of Care Diagnostics Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Point of Care (POC) Diagnostics Market is witnessing steady growth, driven by the increasing need for rapid, accurate, and convenient diagnostic solutions. Point of care diagnostics allow healthcare professionals to conduct tests near or at the patient site, delivering immediate results that enhance treatment decisions and patient outcomes. The market is projected to reach USD 15.3 billion in 2026 and expand to USD 20.3 billion by 2033, growing at a CAGR of 4.1% during the forecast period.
POC diagnostics play a critical role in improving healthcare efficiency by reducing the time between sample collection and diagnosis. The growing prevalence of chronic diseases, infectious disorders, and the rising emphasis on preventive healthcare are further fueling demand for these solutions. Technological advancements such as microfluidics, biosensors, and digital integration are enhancing the precision and usability of point of care devices, driving market expansion.
Market Insights
The Point of Care Diagnostics Market is experiencing rapid growth due to rising awareness about early disease detection and the shift toward decentralized healthcare. Blood glucose monitoring is a leading segment, driven by the global increase in diabetes cases. Infectious disease testing, particularly for COVID-19, influenza, and other viral infections, has seen unprecedented demand, highlighting the importance of timely diagnosis.
Other significant segments include cardiometabolic disease testing, pregnancy and fertility testing, and hematology testing. Home-based testing solutions are increasingly popular, allowing patients to monitor their health conveniently. Additionally, adoption is growing across physician offices, urgent care clinics, and retail clinics, reflecting a broader trend of accessible healthcare solutions outside traditional hospital settings.
Market Drivers
Several factors are propelling growth in the POC diagnostics sector. The rising prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and obesity, has increased demand for rapid and accurate testing solutions. The COVID-19 pandemic underscored the need for immediate, decentralized testing, further accelerating market expansion.
Technological innovations, including device miniaturization, wireless connectivity, and integration with mobile applications, have improved the accuracy and usability of POC devices. Rising patient awareness and healthcare provider adoption of rapid testing methods, coupled with the focus on preventive care, are additional key drivers supporting market growth.
Business Opportunities
The Point of Care Diagnostics Market presents significant opportunities for device manufacturers, healthcare providers, and technology innovators. Companies developing portable, user-friendly devices can capitalize on the growing demand for home testing solutions. Strategic collaborations with hospitals, clinics, and healthcare networks can enhance market penetration and adoption.
Emerging economies offer high-growth potential due to increasing healthcare investments, government initiatives to improve diagnostic access, and the rising burden of infectious and chronic diseases. Innovations that combine rapid diagnostics with digital health solutions are likely to create a competitive advantage for market participants.
Regional Analysis
North America holds a major share of the global POC diagnostics market, driven by advanced healthcare infrastructure, high adoption of innovative technologies, and favorable reimbursement policies. The United States, in particular, is a key market for blood glucose and infectious disease testing.
Europe is witnessing steady growth as preventive healthcare gains traction and the demand for rapid diagnostic solutions increases in hospital and outpatient settings. Germany, France, and the United Kingdom are the leading contributors in the region.
Asia Pacific is projected to record the fastest growth over the forecast period, fueled by rising healthcare expenditure, expanding diagnostic infrastructure, and increasing prevalence of chronic and infectious diseases. China, India, and Japan are prominent markets in this region.
Latin America is gradually adopting point of care diagnostics, supported by government initiatives and increased healthcare access. The Middle East & Africa region is also seeing rising demand, driven by infectious disease outbreaks and growing investment in healthcare infrastructure.
Key Players
The global Point of Care Diagnostics Market is highly competitive, with leading multinational and regional players focusing on technological innovation and strategic partnerships. Prominent companies include
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation (including Beckman Coulter & Cepheid)
- Thermo Fisher Scientific
- QuidelOrtho Corporation
- Becton, Dickinson and Company (BD)
- bioMerieux
- Hologic, Inc.
- Nova Biomedical
- LumiraDx
- OraSure Technologies
- Fujirebio Inc.
- Siemens AG (POC division)
- Sekisui Diagnostics
Market Segmentation
By Product
- Blood Glucose Monitoring
- Infectious Disease Testing
- Cardiometabolic Disease Testing
- Pregnancy & Fertility Testing
- Hematology Testing
- Others
By Sample
- Blood
- Nasal and Oropharyngeal Swabs
- Urine
- Others
By End-User
- Hospital Bedside
- Physician's Office Lab
- Urgent Care & Retail Clinics
- Home & Self Testing
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Point Of Care Diagnostics Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Point Of Care Diagnostics Market Outlook, 2020-2033
- 3.1. Global Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 3.1.1. Blood Glucose Monitoring
- 3.1.2. Infectious Disease Testing
- 3.1.3. Cardiometabolic Disease Testing
- 3.1.4. Pregnancy & Fertility Testing
- 3.1.5. Hematology Testing
- 3.1.6. Others
- 3.2. Global Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
- 3.2.1. Blood
- 3.2.2. Nasal and Oropharyngeal Swabs
- 3.2.3. Urine
- 3.2.4. Others
- 3.3. Global Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
- 3.3.1. Hospital Bedside
- 3.3.2. Physician's Office Lab
- 3.3.3. Urgent Care & Retail Clinics
- 3.3.4. Home & Self Testing
- 3.4. Global Point Of Care Diagnostics Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Point Of Care Diagnostics Market Outlook, 2020-2033
- 4.1. North America Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 4.1.1. Blood Glucose Monitoring
- 4.1.2. Infectious Disease Testing
- 4.1.3. Cardiometabolic Disease Testing
- 4.1.4. Pregnancy & Fertility Testing
- 4.1.5. Hematology Testing
- 4.1.6. Others
- 4.2. North America Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
- 4.2.1. Blood
- 4.2.2. Nasal and Oropharyngeal Swabs
- 4.2.3. Urine
- 4.2.4. Others
- 4.3. North America Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
- 4.3.1. Hospital Bedside
- 4.3.2. Physician's Office Lab
- 4.3.3. Urgent Care & Retail Clinics
- 4.3.4. Home & Self Testing
- 4.4. North America Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 4.4.2. U.S. Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 4.4.3. U.S. Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 4.4.4. Canada Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 4.4.5. Canada Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 4.4.6. Canada Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Point Of Care Diagnostics Market Outlook, 2020-2033
- 5.1. Europe Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 5.1.1. Blood Glucose Monitoring
- 5.1.2. Infectious Disease Testing
- 5.1.3. Cardiometabolic Disease Testing
- 5.1.4. Pregnancy & Fertility Testing
- 5.1.5. Hematology Testing
- 5.1.6. Others
- 5.2. Europe Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
- 5.2.1. Blood
- 5.2.2. Nasal and Oropharyngeal Swabs
- 5.2.3. Urine
- 5.2.4. Others
- 5.3. Europe Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
- 5.3.1. Hospital Bedside
- 5.3.2. Physician's Office Lab
- 5.3.3. Urgent Care & Retail Clinics
- 5.3.4. Home & Self Testing
- 5.4. Europe Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.2. Germany Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.3. Germany Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.4.4. Italy Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.5. Italy Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.6. Italy Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.4.7. France Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.8. France Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.9. France Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.4.10. U.K. Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.11. U.K. Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.12. U.K. Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.4.13. Spain Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.14. Spain Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.15. Spain Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.4.16. Russia Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.17. Russia Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.18. Russia Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.4.19. Rest of Europe Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 5.4.20. Rest of Europe Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 5.4.21. Rest of Europe Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Point Of Care Diagnostics Market Outlook, 2020-2033
- 6.1. Asia Pacific Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 6.1.1. Blood Glucose Monitoring
- 6.1.2. Infectious Disease Testing
- 6.1.3. Cardiometabolic Disease Testing
- 6.1.4. Pregnancy & Fertility Testing
- 6.1.5. Hematology Testing
- 6.1.6. Others
- 6.2. Asia Pacific Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
- 6.2.1. Blood
- 6.2.2. Nasal and Oropharyngeal Swabs
- 6.2.3. Urine
- 6.2.4. Others
- 6.3. Asia Pacific Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
- 6.3.1. Hospital Bedside
- 6.3.2. Physician's Office Lab
- 6.3.3. Urgent Care & Retail Clinics
- 6.3.4. Home & Self Testing
- 6.4. Asia Pacific Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 6.4.2. China Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 6.4.3. China Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 6.4.4. Japan Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 6.4.5. Japan Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 6.4.6. Japan Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 6.4.7. South Korea Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 6.4.8. South Korea Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 6.4.9. South Korea Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 6.4.10. India Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 6.4.11. India Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 6.4.12. India Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 6.4.13. Southeast Asia Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 6.4.14. Southeast Asia Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 6.4.15. Southeast Asia Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 6.4.16. Rest of SAO Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 6.4.17. Rest of SAO Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 6.4.18. Rest of SAO Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Point Of Care Diagnostics Market Outlook, 2020-2033
- 7.1. Latin America Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 7.1.1. Blood Glucose Monitoring
- 7.1.2. Infectious Disease Testing
- 7.1.3. Cardiometabolic Disease Testing
- 7.1.4. Pregnancy & Fertility Testing
- 7.1.5. Hematology Testing
- 7.1.6. Others
- 7.2. Latin America Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
- 7.2.1. Blood
- 7.2.2. Nasal and Oropharyngeal Swabs
- 7.2.3. Urine
- 7.2.4. Others
- 7.3. Latin America Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
- 7.3.1. Hospital Bedside
- 7.3.2. Physician's Office Lab
- 7.3.3. Urgent Care & Retail Clinics
- 7.3.4. Home & Self Testing
- 7.4. Latin America Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 7.4.2. Brazil Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 7.4.3. Brazil Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 7.4.4. Mexico Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 7.4.5. Mexico Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 7.4.6. Mexico Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 7.4.7. Argentina Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 7.4.8. Argentina Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 7.4.9. Argentina Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 7.4.10. Rest of LATAM Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 7.4.11. Rest of LATAM Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 7.4.12. Rest of LATAM Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Point Of Care Diagnostics Market Outlook, 2020-2033
- 8.1. Middle East & Africa Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 8.1.1. Blood Glucose Monitoring
- 8.1.2. Infectious Disease Testing
- 8.1.3. Cardiometabolic Disease Testing
- 8.1.4. Pregnancy & Fertility Testing
- 8.1.5. Hematology Testing
- 8.1.6. Others
- 8.2. Middle East & Africa Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
- 8.2.1. Blood
- 8.2.2. Nasal and Oropharyngeal Swabs
- 8.2.3. Urine
- 8.2.4. Others
- 8.3. Middle East & Africa Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
- 8.3.1. Hospital Bedside
- 8.3.2. Physician's Office Lab
- 8.3.3. Urgent Care & Retail Clinics
- 8.3.4. Home & Self Testing
- 8.4. Middle East & Africa Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 8.4.2. GCC Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 8.4.3. GCC Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 8.4.4. South Africa Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 8.4.5. South Africa Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 8.4.6. South Africa Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 8.4.7. Egypt Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 8.4.8. Egypt Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 8.4.9. Egypt Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 8.4.10. Nigeria Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 8.4.11. Nigeria Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 8.4.12. Nigeria Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 8.4.13. Rest of Middle East Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
- 8.4.14. Rest of Middle East Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
- 8.4.15. Rest of Middle East Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Abbott Laboratories
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Roche Diagnostics
- 9.4.3. Siemens Healthineers
- 9.4.4. Danaher Corporation (including Beckman Coulter & Cepheid)
- 9.4.5. Thermo Fisher Scientific
- 9.4.6. QuidelOrtho Corporation
- 9.4.7. Becton, Dickinson and Company (BD)
- 9.4.8. bioMerieux
- 9.4.9. Hologic, Inc.
- 9.4.10. Nova Biomedical
- 9.4.1. Abbott Laboratories
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
